A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patientsSara Rossi, Giuseppe Campiani, Sandra Gemma et al.|Biomedicine & Pharmacotherapy|2024Cited by 9
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood MalignanciesGabriele Carullo, Giuseppe Campiani, Sara Rossi et al.|ACS Pharmacology & Translational Science|2024Cited by 7